Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCR Sampling Optimization for Chronic Chagas Disease
NCT01678599Phase 4Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of benznidazole in American trypanosomiasis (CD), sponsored by Drugs for Neglected Diseases initiative. Primary endpoints: Positive or negative PCR at baseline and Identification of the optimal relationship between sensitivity and feasibility. Started Apr 2011; status: completed.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on NCT01678599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678599.